The human microbiome in chronic kidney disease: a double-edged sword

E Wehedy, IF Shatat, S Al Khodor - Frontiers in medicine, 2022 - frontiersin.org
Chronic kidney disease (CKD) is an increasing global health burden. Current treatments for
CKD include therapeutics to target factors that contribute to CKD progression, including …

[HTML][HTML] Ten lessons from the Spanish model of organ donation and transplantation

S Streit, C Johnston-Webber, J Mah… - Transplant …, 2023 - frontierspartnerships.org
The organ donation and transplantation program in Spain has long been considered the
gold standard worldwide. An in-depth understanding of the Spanish program may promote …

RICORS2040: the need for collaborative research in chronic kidney disease

A Ortiz - Clinical kidney journal, 2022 - academic.oup.com
Chronic kidney disease (CKD) is a silent and poorly known killer. The current concept of
CKD is relatively young and uptake by the public, physicians and health authorities is not …

Detección de factores de riesgo de enfermedad renal crónica en adultos

AM Iraizoz Barrios, G Brito Sosa… - Revista Cubana de …, 2022 - scielo.sld.cu
Introducción: La enfermedad renal crónica se considera una enfermedad con graves
repercusiones para la sociedad y las políticas de salud, con elevada incidencia y …

The role of disturbed Mg homeostasis in chronic kidney disease comorbidities

C Rodelo-Haad, MV Pendón-Ruiz de Mier… - Frontiers in cell and …, 2020 - frontiersin.org
Some of the critical mechanisms that mediate chronic kidney disease (CKD) progression are
associated with vascular calcifications, disbalance of mineral metabolism, increased …

CKD: The burden of disease invisible to research funders

M Roger, A Osuna Ortega, MC De Gracia Guindo… - 2021 - digibug.ugr.es
The uptake of the current concept of chronic kidney disease (CKD) by the public, physicians
and health authorities is low. Physicians still mix up CKD with chronic kidney insufficiency or …

[PDF][PDF] Prevalence, cardiometabolic comorbidities and reporting of chronic kidney disease; a Hungarian cohort analysis

A Zemplényi, E Sághy, A Kónyi, L Szabó… - … Journal of Public …, 2023 - ssph-journal.org
Objectives: Chronic kidney disease (CKD) implies increased comorbidity burden, disability,
and mortality, becoming a significant public health problem worldwide, however, prevalence …

[HTML][HTML] Epidemiology, clinical profile, management, and two-year risk complications among patients with chronic kidney disease in Spain

C Escobar, U Aranda, B Palacios, M Capel, A Sicras… - nefrologia, 2021 - Elsevier
Objectives To describe the epidemiology, clinical profile, treatments, and to determine
cardiovascular and renal outcomes after two years of follow-up in a contemporary chronic …

MicroRNA-145 and microRNA-486 are potential serum biomarkers for vascular calcification

S Fernández-Villabrille, B Martín-Carro… - Nephrology Dialysis …, 2023 - academic.oup.com
Introduction MicroRNAs (miRs) regulate vascular calcification (VC), and their quantification
may contribute to suspicion of the presence of VC. Methods The study was performed in four …

Twenty years of real-world data to estimate chronic kidney disease prevalence and staging in an unselected population

C Santos-Araújo, L Mendonça… - Clinical Kidney …, 2023 - academic.oup.com
Chronic kidney disease (CKD) represents a global public health burden, but its true
prevalence is not fully characterized in the majority of countries. We studied the CKD …